In conclusion, the present results indicate that oral supplementation of bovine TGF-β2 enriched milk fraction might prove useful in ameliorating the complications of anti-cancer therapy in humans with TGF-β2 unresponsive tumour cells. This evidence concerns the gene TGFB2 and neoplasm.